Merck & Co Inc
BMV:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
BMV:MRK
|
US |
|
0
|
01 Communique Laboratory Inc
OTC:OONEF
|
CA |
|
TOMI Environmental Solutions Inc
NASDAQ:TOMZ
|
US |
|
China Citic Bank Corp Ltd
F:D7C
|
CN |
|
Genenta Science SPA
NASDAQ:GNTA
|
IT |
|
Artea SA
PAR:ARTE
|
FR |
|
Astral Foods Ltd
OTC:ALFDF
|
ZA |
|
Wynnstay Group PLC
LSE:WYN
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MRK's stock price target?
Price Target
2 642.1
MXN
According to Wall Street analysts, the average 1-year price target for 
MRK is 2 642.1 MXN with a low forecast of 1 801.32 MXN and a high forecast of 3 317.28 MXN.
What is the Revenue forecast for Merck & Co Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Gross Profit forecast for Merck & Co Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Merck & Co Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 2%.
What is the Pre-Tax Income forecast for Merck & Co Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Merck & Co Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 8 years is 4%.